Furui Da: In 2025, net profit is expected to decrease by 22.9% year-on-year; it proposes a dividend of 0.57 RMB for every 10 shares.

MetaMuskRat · 2026-04-04T19:14:48+00:00

Furui Da (600223) disclosed its annual report on April 2nd. In 2025, it achieved operating revenue of 3.65B yuan, a year-on-year decrease of 8.33%; net profit attributable to shareholders of the parent company was 188 million yuan, a decrease of 22.9% year-on-year; basic earnings per share were 0.18 yuan. The company plans to distribute a cash dividend of 0.57 yuan per 10 shares (tax included). During the reporting period, the company's cosmetics business was affected by industry slowdown and increased competition, which weakened the revenue contribution of core products of the Aier Doctor brand; the pharmaceutical business was impacted by policies such as centralized drug procurement, leading to declines in market share, sales prices, and sales volume for several products.

MetaMuskRat

2026-04-04 19:14:48

People’s Finance News, April 2. On April 2, Furuida (600223) disclosed its annual report. In 2025, the company recorded operating revenue of RMB 3.65B, a year-over-year decrease of 8.33%; net profit attributable to shareholders of RMB 188 million, a year-over-year decrease of 22.9%; and basic earnings per share of RMB 0.18. The company plans to distribute a cash dividend of RMB 0.57 per 10 shares (tax included). During the reporting period, due to a slowdown in industry growth and intensified competition, its cosmetics business saw a weaker drive from the Dr. Aier brand’s core products on revenue; in the pharmaceutical business, influenced by policy controls such as centralized drug procurement, several products’ markets were affected, and both sales prices and sales volumes declined.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes